Generic Name : Alefacept Pronunciation : ah-LEE-fah-sept Therapeutic Classification : Immunosuppressants ICD Code : Y43.4♦ Safety Labeling Changes Approved By FDA
International- Amevive. Why it is prescribed (Indications) :
This medication is an immunosuppressant, prescribed for moderate to severe psoriasis. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis. When it is not to be taken (Contraindications):
Contraindicated in patients with HIV, and hypersensitivity.
Dosage & When it is to be taken :
The recommended dose is 15 mg given once weekly as an intramuscular injection. How it should be taken :
It comes as a solution to be administered by a healthcare provider into the large muscle. Warnings and Precautions :
* Caution should be exercised in patients with history of cancer, recurrent infection, who are taking radiation therapy, any allergy, who are taking other medications, during pregnancy and breastfeeding.
* It may cause dizziness, do not drive a car or operate machinery while taking this medication.
* It should not be used in children.
* Avoid live vaccination while taking this medication. Side Effects :
♦ Serious Effects - Malignancy and abnormal decrease in lymphocytes.
Most Common - Dizziness, increased cough, muscle pain, nausea, swelling at the injection site and sore throat.
Miscellaneous - Itching, chills, cough, and accidental injury.
* Avoid excess dosage. Storage Conditions :
Store it in refrigerator (2-8°C).
Comment & Contribute
Ask an Expert